TIDMCOG

RNS Number : 0336A

Cambridge Cognition Holdings PLC

23 May 2019

Cambridge Cognition Holdings Plc

('Cambridge Cognition' or the 'Company')

Result of AGM and Board Changes

Cambridge Cognition Holdings plc ("the Company"), which develops and markets neuroscience technology to assess brain health, held its Annual General Meeting ("AGM") at 10.00am at the registered office of the Company, Tunbridge Court, Tunbridge Lane, Bottisham, Cambridge, CB25 9TU. All resolutions put to the AGM were duly passed.

Confirmation of Board Changes

Michael Lewis and Nicholas Kerton did not offer themselves for re-election as Non-Executive Directors of the Company and therefore retire from the Board by rotation.

Steven Powell has stepped down as Chief Executive Officer of the Company and his appointment as a Non-Executive Director and as Chairman of the Board of Directors was confirmed at the AGM. In addition to his Chairman duties Steven will continue to play a significant role in key long-term corporate and R&D strategies of the Company.

Matthew Stork, the Company's recently appointed Chief Operating Officer, has joined the Board as Chief Executive Officer. He has expertise in a broad range of healthcare sectors including healthcare IT (including AI), diagnostic imaging, clinical service delivery and pharmaceuticals. He has held executive roles at the InHealth Group, General Electric, ArjoHuntleigh, Canon Medical Systems (formerly Toshiba Medical Systems) and Smith & Nephew. Further information on his appointment is set out below.

The Company will seek to appoint an additional independent Non-Executive Director within the next two months.

Enquiries

 
 Cambridge Cognition Holdings PLC 
  Steven Powell, Chief Executive Officer        Tel: 01223 810 700 
  Matthew Stork, Chief Operating Officer        press@camcog.com 
 finnCap Ltd (NOMAD and Joint Broker)         Tel: 020 7220 0500 
  Geoff Nash / Simon Hicks                     (Corporate Finance) 
  Alice Lane/Manasa Patil                      (ECM) 
 Dowgate Capital Limited (Joint Broker)       Tel: 020 3903 7715 
  David Poutney / James Serjeant 
 IFC Advisory Ltd (Financial PR and IR)       Tel: 020 3934 6630 
  Graham Herring / Miles Nolan / Zach Cohen

About Cambridge Cognition

Cambridge Cognition is a neuroscience technology company developing digital health products to better understand, detect and treat conditions affecting brain health. The company's software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early, and reduce global R&D and healthcare costs.

For further information visit www.cambridgecognition.com

The following information is disclosed pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies:

Matthew William Stork (aged 50) has been a director of the following companies during the five years preceding the date of this announcement:

Current directorships

MIH Holdings Limited

Previous directorships

n/a

There is no further information to be disclosed pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

MSCAJMJTMBJTBTL

(END) Dow Jones Newswires

May 23, 2019 09:35 ET (13:35 GMT)

Cambridge Cognition (LSE:COG)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Cambridge Cognition Charts.
Cambridge Cognition (LSE:COG)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Cambridge Cognition Charts.